- cross-posted to:
- [email protected]
- cross-posted to:
- [email protected]
Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.
Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.
More likely is a background/credit check service that runs statistical analysis on genetic factors that correlate with late payments or property damage as part of their renter screening service.
Hold my techbro, this smells like a case of VC funded startup!!
“It’s not racist bro, it’s just a statistical analysis on genetic factors that correlate with late payments or property damage.
It’ll be the next big thing, I swear we keep the DNA on our own blockchain, we call it the doublechainix. You get it bro??”
“And we’ll make a sweet app where we can charge people $20 for access to their own data bro!”